Sema4’s post-money valuation exceeds $1 billion STAMFORD, CT — July 28, 2020 — Sema4, a patient-centered health intelligence company, today announced that funds managed by BlackRock led its oversubscribed Series C...read more
Category - Database
Genomics England launches next-generation research platform central to UK COVID-19 response
British tech company Lifebit and Amazon Web Services to support a dedicated environment for researchers working on COVID-19 vaccines and treatments Genomics England (GEL) has today launched a next-generation genomic...read more
Bluebee’s coherent data strategy set to unify Illumina’s data analytics products
This month’s attention-grabbing headlines in the field of genomics, genetics, and precision medicine can undoubtedly be attributed to the acquisition of Bluebee by Illumina. I spoke with Hans Cobben, CEO of Bluebee and...read more
Syapse Announces $30M Financing to Advance the Use of Real-World Evidence
SAN FRANCISCO, May 28, 2020 (GLOBE NEWSWIRE) — Syapse, today announced $30 million in new equity funding to accelerate the creation and use of real-world evidence in oncology. The financing was led by Revelation...read more
